RATIONALE: Patients with end-stage renal disease (ESRD) are characterized by increased cardiovascular (CV) and all-cause mortality due to advanced remodeling of the macro- and microvascular beds. OBJECTIVE: The aim of this study was to determine whether retinal microvascular function can predict all-cause and CV mortality in patients with ESRD. METHODS AND RESULTS: In the multicenter prospective observational ISAR (Risk Stratification in End-Stage Renal Disease) study, data on dynamic retinal vessel analysis (DVA) was available in a sub-cohort of 214 dialysis patients (mean age 62.6{plus minus}15.0; 32% female). Microvascular dysfunction was quantified by measuring maximum arteriolar (aMax) and venular dilation (vMax) of retinal vessels in response to flicker light stimulation. During a mean follow-up of 44 months, 55 patients died, including 25 CV and 30 non-CV fatal events. vMax emerged as a strong independent predictor for all-cause mortality. In the Kaplan-Meier analysis, individuals within the lowest tertile of vMax showed significantly shorter three-year survival rates than those within the highest tertile (66.9{plus minus}5.8% vs 92.4{plus minus}3.3%). Uni- and multivariate hazard ratios for all-cause mortality per SD increase of vMax were 0.62 [0.47;0.82] and 0.65[0.47;0.91], respectively. aMax and vMax were able to significantly predict nonfatal and fatal CV events (HR 0.74[0.57;0.97] and 0.78[0.61;0.99], respectively). CONCLUSIONS: Our results provide the first evidence that impaired retinal venular dilation is a strong and independent predictor of all-cause mortality in hemodialyzed ESRD patients. DVA provides added value for prediction of all-cause mortality and may be a novel diagnostic tool to optimize CV risk stratification in ESRD and other high-risk CV cohorts. CLINICAL TRIAL REGISTRATION: NCT01152892.
RATIONALE: Patients with end-stage renal disease (ESRD) are characterized by increased cardiovascular (CV) and all-cause mortality due to advanced remodeling of the macro- and microvascular beds. OBJECTIVE: The aim of this study was to determine whether retinal microvascular function can predict all-cause and CV mortality in patients with ESRD. METHODS AND RESULTS: In the multicenter prospective observational ISAR (Risk Stratification in End-Stage Renal Disease) study, data on dynamic retinal vessel analysis (DVA) was available in a sub-cohort of 214 dialysis patients (mean age 62.6{plus minus}15.0; 32% female). Microvascular dysfunction was quantified by measuring maximum arteriolar (aMax) and venular dilation (vMax) of retinal vessels in response to flicker light stimulation. During a mean follow-up of 44 months, 55 patients died, including 25 CV and 30 non-CV fatal events. vMax emerged as a strong independent predictor for all-cause mortality. In the Kaplan-Meier analysis, individuals within the lowest tertile of vMax showed significantly shorter three-year survival rates than those within the highest tertile (66.9{plus minus}5.8% vs 92.4{plus minus}3.3%). Uni- and multivariate hazard ratios for all-cause mortality per SD increase of vMax were 0.62 [0.47;0.82] and 0.65[0.47;0.91], respectively. aMax and vMax were able to significantly predict nonfatal and fatal CV events (HR 0.74[0.57;0.97] and 0.78[0.61;0.99], respectively). CONCLUSIONS: Our results provide the first evidence that impaired retinal venular dilation is a strong and independent predictor of all-cause mortality in hemodialyzed ESRDpatients. DVA provides added value for prediction of all-cause mortality and may be a novel diagnostic tool to optimize CV risk stratification in ESRD and other high-risk CV cohorts. CLINICAL TRIAL REGISTRATION: NCT01152892.
Authors: Lukas Streese; Joséphine Gander; Justin Carrard; Christoph Hauser; Timo Hinrichs; Arno Schmidt-Trucksäss; Konstantin Gugleta; Henner Hanssen Journal: BMJ Open Date: 2022-06-06 Impact factor: 3.006
Authors: Stanislas Werfel; Georg Lorenz; Bernhard Haller; Roman Günthner; Julia Matschkal; Matthias C Braunisch; Carolin Schaller; Peter Gundel; Stephan Kemmner; Salim S Hayek; Christian Nusshag; Jochen Reiser; Philipp Moog; Uwe Heemann; Christoph Schmaderer Journal: Sci Rep Date: 2021-04-29 Impact factor: 4.379
Authors: Siegfried K Wagner; Dun Jack Fu; Livia Faes; Xiaoxuan Liu; Josef Huemer; Hagar Khalid; Daniel Ferraz; Edward Korot; Christopher Kelly; Konstantinos Balaskas; Alastair K Denniston; Pearse A Keane Journal: Transl Vis Sci Technol Date: 2020-02-12 Impact factor: 3.283
Authors: Yvonne Alexander; Elena Osto; Arno Schmidt-Trucksäss; Michael Shechter; Danijela Trifunovic; Dirk J Duncker; Victor Aboyans; Magnus Bäck; Lina Badimon; Francesco Cosentino; Marco De Carlo; Maria Dorobantu; David G Harrison; Tomasz J Guzik; Imo Hoefer; Paul D Morris; Giuseppe D Norata; Rosa Suades; Stefano Taddei; Gemma Vilahur; Johannes Waltenberger; Christian Weber; Fiona Wilkinson; Marie-Luce Bochaton-Piallat; Paul C Evans Journal: Cardiovasc Res Date: 2021-01-01 Impact factor: 10.787
Authors: Emanuel Zampiccoli; Jens Barthelmes; Leonie Kreysing; Matthias P Nägele; Delia Nebunu; Thomas Haider; Arnold von Eckardstein; Bernhard Gerber; Rahel Schwotzer; Frank Ruschitzka; Isabella Sudano; Andreas J Flammer Journal: ESC Heart Fail Date: 2022-01-21
Authors: Armand M A Linkens; Alfons J H M Houben; Abraham A Kroon; Miranda T Schram; Tos T J M Berendschot; Carroll A B Webers; Marleen van Greevenbroek; Ronald M A Henry; Bastiaan de Galan; Coen D A Stehouwer; Simone J M P Eussen; Casper G Schalkwijk Journal: Am J Clin Nutr Date: 2022-02-09 Impact factor: 7.045